Product
Low-Dose Naltrexone
2 clinical trials
2 indications
Indication
Chronic Fatigue SyndromeIndication
ME/CFSClinical trial
A Double Blind Randomized Trial of Low-dose Naltrexone for Post-COVID Fatigue SyndromeStatus: Recruiting, Estimated PCD: 2024-12-01